Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-090469

Chief Business Officer sold 200,000 shares at $8.74 ($1,748,180)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
TAYTON-MARTIN HELEN KATRINA Chief Business Officer 2020-08-03 Sale −200,000 $8.74 $1,748,180 0 D: show line 1 in the form
Open-market sales · 200,000 sh · avg $8.74 · $1,748,180
Loading xslF345X03/a4.xml…